Stocks and Investing Stocks and Investing
Mon, April 17, 2023
Sun, April 16, 2023
Fri, April 14, 2023
Thu, April 13, 2023

Carter Gould Maintained (ABBV) at Hold with Increased Target to $160 on, Apr 13th, 2023


Published on 2024-10-28 02:45:00 - WOPRAI, Carter Gould
  Print publication without navigation


Carter Gould of Barclays, Maintained "AbbVie Inc." (ABBV) at Hold with Increased Target from $155 to $160 on, Apr 13th, 2023.

Carter has made no other calls on ABBV in the last 4 months.



There are 12 other peers that have a rating on ABBV. Out of the 12 peers that are also analyzing ABBV, 6 agree with Carter's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jasper Hellweg of "Argus Research" Downgraded from Strong Buy to Hold on, Wednesday, April 5th, 2023
  • Tim Anderson of "Wolfe Research" Downgraded from Buy to Hold on, Wednesday, February 22nd, 2023
  • Navin Jacob of "UBS" Maintained at Hold with Increased Target to $152 on, Friday, February 10th, 2023
  • David Risinger of "SVB Leerink" Upgraded from Sell to Hold and Increased Target to $153 on, Friday, February 10th, 2023
  • Steve Chesney of "Atlantic Equities" Maintained at Hold with Decreased Target to $154 on, Friday, February 10th, 2023
  • Geoff Meacham of "B of A Securities" Maintained at Hold with Increased Target to $165 on, Wednesday, December 14th, 2022


These are the ratings of the 6 analyists that currently disagree with Carter


  • Terence Flynn of "Morgan Stanley" Maintained at Buy with Increased Target to $181 on, Monday, April 10th, 2023
  • Vamil Divan of "Guggenheim" Initiated at Strong Buy and Held Target at $172 on, Wednesday, March 1st, 2023
  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $163 on, Friday, February 10th, 2023
  • Gavin Clark-Gartner of "Evercore ISI Group" Maintained at Buy with Increased Target to $165 on, Thursday, February 9th, 2023
  • Robyn Karnauskas of "Truist Securities" Reiterated at Strong Buy and Held Target at $180 on, Thursday, February 9th, 2023
  • Gary Nachman of "BMO Capital" Maintained at Buy with Decreased Target to $167 on, Monday, February 6th, 2023